Advances and challenges in immunotherapy of small cell lung cancer

Small cell lung cancer (SCLC) is a highly lethal disease, characterized by early metastasis and rapid growth, and no effective treatment after relapse. Etoposide-platinum (EP) combination has been the backbone therapy of SCLC over the past 30 years. It is extremely urgent and important to seek new t...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hanfei, Li, Lingyu, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072020/
https://www.ncbi.nlm.nih.gov/pubmed/32194311
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.01.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072020/
https://www.ncbi.nlm.nih.gov/pubmed/32194311
http://dx.doi.org/10.21147/j.issn.1000-9604.2020.01.13

Ejemplares similares